Accredo offers a wide range of medications to treat various complex and chronic conditions. Visit Conditions to learn more about treatment, medications, and support for your condition.
| Medication | Condition(s) | Generic/Biosimilar | Manufacturer |
|---|---|---|---|
| Rituxan Hycela™ (rituximab hyaluronidase) |
Leukemia
|
Genentech USA, Inc. | |
| Rituxan® (rituximab) | Biosimilar(s) available | Genentech, Inc. and Biogen, Inc. | |
| Rixubis (coagulation factor IX [recombinant]) |
Bleeding disorders
|
Takeda Pharmaceuticals | |
| Roctavian® (valoctocogene roxaparvovec-rvox); | BioMarin Pharmaceutical, Inc. | ||
| Rozlytrek® (entrectinib) | Genentech USA, Inc. | ||
| Rubraca® (rucaparib) | Clovis Oncology | ||
| Ruconest® (C1 esterase inhibitor) | Pharming Healthcare, Inc. | ||
| Rukobia (fostemsavir) | ViiV Healthcare | ||
| Ruxience™ (rituximab-pvvr) | Biosimilar | Pfizer, Inc. | |
| Rybrevant™ (amivantamab-vmjw) |
Lung cancer
|
Janssen Biotech, Inc. |